These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1110 related items for PubMed ID: 15337695
21. Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial). Yancy CW, Singh A. Am J Cardiol; 2006 Jul 15; 98(2):226-9. PubMed ID: 16828598 [Abstract] [Full Text] [Related]
22. The effect of nesiritide on renal function and other clinical parameters in patients with decompensated heart failure and preserved ejection fraction. Kelesidis I, Mazurek J, Khullar P, Saeed W, Vittorio T, Zolty R. Congest Heart Fail; 2012 Jul 15; 18(3):158-64. PubMed ID: 22497779 [Abstract] [Full Text] [Related]
23. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Burger AJ, Horton DP, LeJemtel T, Ghali JK, Torre G, Dennish G, Koren M, Dinerman J, Silver M, Cheng ML, Elkayam U, Prospective Randomized Evaluation of Cardiac Ectopy with Dobutamine or Natrecor Therapy. Am Heart J; 2002 Dec 15; 144(6):1102-8. PubMed ID: 12486437 [Abstract] [Full Text] [Related]
26. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC. Mehra MR, McCluskey T, Barr M, Bourge RC, Jessup ML, Mancini D, Radovancevic B, Rayburn B, Taylor DO, Lilly-Hersley J, Linde P. Am Heart J; 2007 Jun 15; 153(6):932-40. PubMed ID: 17540193 [Abstract] [Full Text] [Related]
27. Renal response to candoxatrilat in patients with heart failure. Good JM, Peters M, Wilkins M, Jackson N, Oakley CM, Cleland JG. J Am Coll Cardiol; 1995 May 15; 25(6):1273-81. PubMed ID: 7722120 [Abstract] [Full Text] [Related]
28. Effect of nesiritide in isolated right ventricular failure secondary to pulmonary hypertension. Kelesidis I, Mazurek JA, Saeed W, Chaudhari R, Velankar P, Zolty R. Congest Heart Fail; 2012 May 15; 18(1):18-24. PubMed ID: 22277173 [Abstract] [Full Text] [Related]
32. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC, CKI-201 and CKI-202 Investigators. J Am Coll Cardiol; 2007 Oct 16; 50(16):1551-60. PubMed ID: 17936154 [Abstract] [Full Text] [Related]
33. Nesiritide as bridge to multi-organ transplantation: a case report. Cochrane AB, Fedson SE, Cronin DC. Transplant Proc; 2007 Oct 16; 39(1):308-10. PubMed ID: 17275531 [Abstract] [Full Text] [Related]
34. Hemodynamic effects and safety of nesiritide in neonates with heart failure. Simsic JM, Mahle WT, Cuadrado A, Kirshbom PM, Maher KO. J Intensive Care Med; 2008 Oct 16; 23(6):389-95. PubMed ID: 18805856 [Abstract] [Full Text] [Related]
37. Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow. Ezekowitz JA, Hernandez AF, O'Connor CM, Starling RC, Proulx G, Weiss MH, Bakal JA, Califf RM, McMurray JJ, Armstrong PW. J Am Coll Cardiol; 2012 Apr 17; 59(16):1441-8. PubMed ID: 22497823 [Abstract] [Full Text] [Related]